Key facts
- This page summarizes Beth Zelnick Kaufman's Form 4 filing for CorMedix Inc. (CRMD).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Sep 2025, 21:45.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
This transaction was executed in multiple trades at prices ranging from $12.83 to $13.82. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Footnote F2
These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.